Company Filing History:
Years Active: 2006
Title: Innovations in Carnitine Quantification by GianFranco Fornasini
Introduction
GianFranco Fornasini is an accomplished inventor based in North Bethesda, MD (US). He has made significant contributions to the field of medical diagnostics, particularly in the quantification of carnitine levels in dialysis patients. His innovative approach has the potential to improve patient care and management.
Latest Patents
Fornasini holds a patent for the "Quantification of carnitine levels in dialysis patients." This patent discloses methods for diagnosing carnitine deficiency and quantifying that deficiency, allowing for easy and accurate tracking of carnitine concentrations over time. The methods are designed to be high throughput and low cost, providing high sensitivity and accuracy for monitoring patient status and managing therapies for carnitine deficiency. The preferred embodiments utilize plasma samples taken from patients and dried on filter paper, which are later analyzed using electrospray tandem mass-spectrometry.
Career Highlights
GianFranco Fornasini has worked at Sigma-Tau Pharmaceuticals, Inc., where he has been able to apply his expertise in medical diagnostics. His work has focused on developing methods that enhance the accuracy and efficiency of diagnosing carnitine deficiency in patients undergoing dialysis procedures.
Collaborations
Fornasini has collaborated with Donald H. Chace, furthering the research and development of innovative diagnostic methods in the medical field.
Conclusion
GianFranco Fornasini's contributions to the quantification of carnitine levels represent a significant advancement in patient diagnostics and management. His innovative methods have the potential to greatly enhance the quality of care for dialysis patients.